RxDoctor Payments Data

Antonio Caycedo, MD

Colon & Rectal Surgery · Orlando, FLNPI 1528765831

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 48.3% of the total. 2025 is the largest year on record at $14,632, 6.8 times the $2,157 reported in 2023.

$21,312in general payments, 2019–2025

Across 53 payments — averaging $402.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$10K
  • Applied Medical Resources Corporation$4K
  • Medtronic$4K
  • Intuitive Surgical$2K
  • Johnson & Johnson$245
  • Integra Lifesciences Corporation$164
  • plus $781 from 9 others

What the payments were for

  • Consulting fees$11,42354%
  • Speaking & faculty fees$3,00014%
  • Travel & lodging$4,23020%
  • Food & beverage$2,65912%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,312 in reported general payments places this provider in the 75th percentile of 157 colon & rectal surgery providers in Florida.

See all colon & rectal surgery providers in Florida

Medicare billing

Part B allowed, 2024
$51,783
Medicare patients
72
Services billed
198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate17$100
Metronidazole18$38

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →